Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 968

Similar articles for PubMed (Select 9609085)

1.

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW.

Circulation. 1998 May 19;97(19):1921-9.

2.

Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.

Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Frampton C, Crozier IG, Smyth DW.

Heart. 1999 Feb;81(2):114-20.

3.

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.

Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG.

Circulation. 2003 Jun 10;107(22):2786-92. Epub 2003 May 27.

6.

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N; Christchurch Cardioendocrine Research Group; Australia-New Zealand Heart Failure Group.

J Am Coll Cardiol. 2006 Jan 3;47(1):52-60. Epub 2005 Dec 15.

7.

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, Daikoku S, Matsumoto T, Miyazaki S, Matsuoka H, Takishita S, Kangawa K, Matsuo H, Nonogi H.

Am Heart J. 1998 Jan;135(1):21-8.

PMID:
9453517
8.

Value of brain natriuretic peptide after acute myocardial infarction.

Güneş Y, Okçün B, Kavlak E, Erbaş C, Karcier S.

Anadolu Kardiyol Derg. 2008 Jun;8(3):182-7.

9.

Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.

Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K.

J Card Fail. 2005 Sep;11(7):492-7.

PMID:
16198243
10.

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.

Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.

Am Heart J. 2003 Oct;146(4):729-35.

PMID:
14564330
11.

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

Choy AM, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NS, Struthers AD.

Br Heart J. 1994 Jul;72(1):16-22.

12.

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.

Arakawa N, Nakamura M, Aoki H, Hiramori K.

J Am Coll Cardiol. 1996 Jun;27(7):1656-61.

13.

Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.

Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.

Int J Cardiol. 2005 Sep 15;104(1):39-45.

PMID:
16137508
14.

Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.

Sarullo FM, Gristina T, Brusca I, Serio G, Taormina A, La Chiusa SM, Castello A, Borruso E, Paterna S, Di Pasquale P.

Minerva Cardioangiol. 2007 Apr;55(2):149-55.

PMID:
17342035
15.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
16.

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL.

Cardiovasc Res. 1997 Nov;36(2):246-55. Erratum in: Cardiovasc Res 1999 Nov;44(2):452-3.

17.

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

Davidson NC, Naas AA, Hanson JK, Kennedy NS, Coutie WJ, Struthers AD.

Am J Cardiol. 1996 Apr 15;77(10):828-31.

PMID:
8623734
18.

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.

Palmer BR, Pilbrow AP, Yandle TG, Frampton CM, Richards AM, Nicholls MG, Cameron VA.

J Am Coll Cardiol. 2003 Mar 5;41(5):729-36.

19.

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

Talwar S, Squire IB, Downie PF, Mccullough AM, Campton MC, Davies JE, Barnett DB, Ng LL.

Eur Heart J. 2000 Sep;21(18):1514-21.

20.

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.

Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K.

Circulation. 2002 Dec 3;106(23):2913-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk